Syros Pharmaceuticals Inc’s recently made public that its Affiliate Flagship Pioneering Fund VII, acquired Company’s shares for reported $0.27 million on Dec 27 ’24. In the deal valued at $0.24 per share,1,135,308 shares were bought.
Then, AKKARAJU SRINIVAS bought 9,333 shares, generating $2,306 in total proceeds.
Before that, Flagship Pioneering Fund VII, bought 1,331,624 shares. Syros Pharmaceuticals Inc shares valued at $279,641 were divested by the Affiliate at a price of $0.21 per share.
H.C. Wainwright upgraded its Syros Pharmaceuticals Inc [SYRS] rating to a Buy from a a Neutral in a research note published on November 04, 2020; the price target was increased to $15 from $11. A number of analysts have revised their coverage, including Alliance Global Partners’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Wedbush also remained covering SYRS and has decreased its forecast on January 17, 2020 with a “Neutral” recommendation from previously “an Outperform” rating.
Price Performance Review of SYRS
On Tuesday, Syros Pharmaceuticals Inc [NASDAQ:SYRS] saw its stock fall -4.74% to $0.21. Over the last five days, the stock has lost -1.51%. Syros Pharmaceuticals Inc shares have fallen nearly -9.05% since the year began. Nevertheless, the stocks have fallen -96.85% over the past one year. While a 52-week high of $7.96 was reached on 01/06/25, a 52-week low of $0.18 was recorded on 01/10/25. SMA at 50 days reached $0.4864, while 200 days put it at $3.1289.
Levels Of Support And Resistance For SYRS Stock
The 24-hour chart illustrates a support level at 0.1970, which if violated will result in even more drops to 0.1851. On the upside, there is a resistance level at 0.2240. A further resistance level may holdings at 0.2391. The Relative Strength Index (RSI) on the 14-day chart is 36.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0178, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.29%. Stochastics %K at 18.73% indicates the stock is a buying.
How much short interest is there in Syros Pharmaceuticals Inc?
A steep rise in short interest was recorded in Syros Pharmaceuticals Inc stocks on 2024-12-31, dropping by -1.14 million shares to a total of 1.1 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 2.23 million shares. There was a decline of -103.25%, which implies that there is a negative sentiment for the stock.
